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Transient receptor potential melastatin-like 7
(TRPM7) is a channel protein that also contains
a regulatory serine-threonine kinase domain. Here,
we find that Trpm7/ T cells are deficient in
Fas-receptor-induced apoptosis and that TRPM7
channel activity participates in the apoptotic process
and is regulated by caspase-dependent cleavage.
This function of TRPM7 is dependent on its function
as a channel, but not as a kinase. TRPM7 is cleaved
by caspases at D1510, disassociating the carboxy-
terminal kinase domain from the pore without dis-
rupting the phosphotransferase activity of the
released kinase but substantially increasing TRPM7
ion channel activity. Furthermore, we show that
TRPM7 regulates endocytic compartmentalization
of the Fas receptor after receptor stimulation, an
important process for apoptotic signaling through
Fas receptors. These findings raise the possibility
that other members of the TRP channel superfamily
are also regulated by caspase-mediated cleavage,
with wide-ranging implications for cell death and
differentiation.
INTRODUCTION
Transient receptor potential melastatin-like 7 (TRPM7),
a member of the TRPM subgroup of transient receptor potential
(TRP) channels, is a large (1,862 aa, 210 kDa) protein that
contains both a cation-conducting pore and a serine-threonine
kinase—an unusual molecular configuration often referred to
as a ‘‘chanzyme’’ for its channel-enzyme bifunctionality (Nadler
et al., 2001; Runnels et al., 2001). TRPM7 is nonselective among
cations but is permeant to and inhibitable by intracellular Mg2+
(Kozak and Cahalan, 2003; Nadler et al., 2001). Conducting
only a few pA of inward current at physiological pH, it is potenti-
ated at low extracellular pH (Jiang et al., 2005) and by phospho-Developmlipase C-linked receptors in intact cells (Langeslag et al., 2007).
Trpm7/ embryos do not survive past day 7 of embryogenesis
(Jin et al., 2008), indicating that TRPM7 has an essential and
nonredundant role in mouse development. TRPM7 is expressed
in all cell types examined (Kunert-Keil et al., 2006; Ramsey et al.,
2006), and organ development is widely disrupted in tissue-
specific Trpm7/-deficient mice (Jin et al., 2012). Similarly,
selective deletion of Trpm7 in the T cell lineage disrupts
thymocyte development and accelerates thymic involution (Jin
et al., 2008).
TRPM7’s carboxy-terminal kinase is homologous to a family of
atypical serine-threonine kinases called a-kinases and is struc-
turally similar to protein kinase A (PKA) (Yamaguchi et al.,
2001). TRPM7 autophosphorylates at multiple sites and can
phosphorylate annexin A1 (Dorovkov and Ryazanov, 2004) and
myosin IIA heavy chain (Clark et al., 2008), although its natural
substrates are not known. The proximity of the kinase domain
to the Mg2+-permeating but nonselective pore may be of signif-
icance to signal transduction, with TRPM7 mediating a localized
cation flux (Ca2+, Na+, Mg2+, and trace ions such as Zn2+) either
at the plasma membrane or via specialized intracellular vesicles.
The kinase domain, in turn, has been proposed to be involved in
mediating the inhibition of TRPM7 channel by serving as
a binding site for Mg2+ and Mg2+-bound nucleotides (Demeuse
et al., 2006). Alternatively, because the KD for Mg
2+ inhibition
of TRPM7 is 0.6 mM (Nadler et al., 2001), near physiological
levels of free Mg2+ (0.5 ± 0.2 mM) (Romani and Scarpa, 2000),
and ATP is the primary regulator of free Mg2+, TRPM7 may be
a metabolic sensor. Environmental acidic pH (Jiang et al.,
2005), high intracellular PIP2 (Runnels et al., 2002), and high
internal ATP levels (low free Mg2+) should maximize TRPM7
channel activity. A proposed requirement of TRPM7 in vertebrate
Mg2+ homeostasis (Ryazanova et al., 2010; Schmitz et al., 2003)
is incongruent with the evidence that TRPM7 currents are small
at physiological membrane potentials (<10 pA at 60mV), the
recent identification of ubiquitous Mg2+ transporters (Li et al.,
2011; Zhou and Clapham, 2009), and our finding that Trpm7/
lymphocytes and other cell types are not deficient in acute
Mg2+ uptake when exposed to extracellular 10 mM Mg2+, or at
steady state in total Mg2+ levels (Jin et al., 2008, 2012). Impor-
tantly, the Mg2+ permeability of TRPM7 may be of greaterental Cell 22, 1149–1162, June 12, 2012 ª2012 Elsevier Inc. 1149
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Figure 1. TRPM7-Deficient T Cells Are Defi-
cient in Activation-Induced Apoptosis and
Fas-Induced Apoptosis
(A) AICDmeasured by staining ofWT (blue) and KO
(red) T cells with annexin 5-Alexa 488 15 hr after
stimulation. Bar graphs illustrate percentage of
cells stained positive for cell-surface phosphati-
dylserine by ANXA5-Alexa 488 (ANXA5+) in un-
stimulated (untx) and cells stimulated with plate-
bound anti-CD3 antibody for 15 hr (average ±
SEM, n = 4). Right panel shows AICD after 30 hr of
restimulation. Bar graphs present percentage of
ANXA5+ cells after 30 hr of restimulation (±SEM,
n = 4). Representative flow cytometry histograms
are shown in Figure S1A.
(B) Reduced caspase activity in KO T cells 24 hr
after restimulation with anti-CD3 and anti-CD28
antibodies. Bar graphs show percentage of cells
with retained FAM-VAD-FMK (left) and mean
fluorescence intensity (MFI) of FAM-VAD-FMK-
positive T cells (right; ±SEM, n = 9).
(C) Detection of apoptosis by annexin A5 staining
(ANXA5+) in WT (blue) and KO (red) T cells after
Fas receptor stimulation with increasing concen-
trations of anti-Fas antibody (±SEM, n = 4).
Representative flow cytometry histograms are
shown in Figure S1B.
(D) Percentage of ANXA5+ T cells before and after
Fas-induced apoptosis in WT (blue) and KO (red)
Tcells (plate-boundanti-Fasantibody;±SEM,n=4).
(E) Activation-induced cell surface upregulation of Fas or Fas receptor (FasR) as measured by staining with anti-FasR-FITC on activated WT T cells (black) and
KO T cells (red) over typical naive T cells (gray). Bar graph illustrates average change in FasR-FITC expression on WT and KO T cells before and after activation
(MFI of FasR-FITC staining; ±SD, n = 2).
See also Figure S1.
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Fas Signaling Regulates TRPM7 by Caspase Cleavagesignificance to intracellular signals that respond to highly local-
ized intracellular Mg2+ around the intracellular mouth of
TRPM7 channels.
Using Trpm7fl/ (lck Cre)mice (also referred to as TM7/mice)
with selectively targeted deletion of Trpm7 in the T cell lineage,
we showed that TRPM7 is required for normal T cell develop-
ment and that a large fraction of Trpm7/ thymocytes arrest
their thymic development at the DN3 stage, described by the
cell surface immunophenotype CD4-CD8-CD44-CD25+ (Jin
et al., 2008). The thymocytes that escape this developmental
block, presumably by delayed deletion of Trpm7, survive and
populate the peripheral lymphoid organs, albeit with a lower
number of T cells. Interestingly, TRPM7 is deleted efficiently in
these peripheral T cells (Jin et al., 2008), providing an opportunity
to study TRPM7 in a postdevelopmental system. We have now
investigated these peripheral Trpm7/ T cells from TM7/
mice in search of molecular mechanisms involved in the regula-
tion and function of TRPM7. We show here that regulation of
TRPM7 through caspase-mediated cleavage is important for
Fas-induced apoptosis.
RESULTS
Trpm7–/– T Cells Show Markedly Reduced Activation-
Induced Cell Death
In the process of studying T cell activation, we observed that in
contrast to wild-type (WT) T cells, Trpm7/ T cells do not
show a substantial decrease in viability after T cell receptor1150 Developmental Cell 22, 1149–1162, June 12, 2012 ª2012 Elsev(TCR) restimulation. Based on these observations, we investi-
gated the phenomenon of activation-induced cell death (AICD),
also referred to as restimulation-induced cell death (RICD),
which results in the apoptosis of T cells upon repeated TCR stim-
ulation (Green et al., 2003; Krammer et al., 2007). When actively
growing WT T cells were restimulated with anti-CD3 antibodies,
the percentage of annexin A5-positive (ANXA5+) cells increased
from 15% to 35% after 15 hr of restimulation (Figure 1A; see Fig-
ure S1A available online). In contrast, AICD in Trpm7/ T cells
was significantly blunted (Figures 1A and S1A). The difference
was also seen when AICD was measured after 30 hr of restimu-
lation (Figures 1A and S1A). Accordingly, Trpm7/ T cells are
also deficient in activation of caspases as measured by FAM-
VAD-FMK, a fluorescent cell-permeable probe of caspase
activity (Figure 1B). Because AICD is dependent on death-
receptor signaling (Krammer et al., 2007), we tested the sensi-
tivity to Fas-induced apoptosis in Trpm7/ T cells.
Trpm7–/– T Cells Are Defective in FAS Receptor-Induced
Apoptosis
Actively growing T cells were stimulated with anti-Fas agonist
antibody and crosslinking agent, Protein G, and the resulting
apoptosis was measured by ANXA5 staining (Figure 1C). Flow
cytometric histograms representing the increase in the
percentage of ANXA5+ cells in response to increasing concen-
trations of anti-Fas agonist antibody are shown as overlays of
WT and Trpm7/ (KO) T cells (Figure S1B). These results indi-
cate that Trpm7/ T cells are significantly less sensitive toier Inc.
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Figure 2. TRPM7 Channel, but Not Kinase, Activity Participates in Fas-Induced Apoptosis
(A) Quantitative real-time PCR showing efficient Trpm7 mRNA knockdown in Jurkat cells to 30% of control (±SEM, n = 3).
(B) Native ITRPM7 in Jurkat cells infected with control lentiviral shRNA. Plotted are peak outward currents measured from repeated 300 ms ramps at 2 s intervals
from100mV to +100mV (see Figure S5 for details). Characteristically, ITRPM7 slowly increases after patch-pipette ‘‘break-in’’ and dialysis of intracellular Mg2+ out
of the cell. Both the increase in current after break-in and its inhibition by perfusion with 5 mM Mg2+ are characteristic of ITRPM7.
(C) ITRPM7 is reduced 10-fold (compare to B; note y axis scale change) in Jurkat cell that had been infected with TRPM7-specific lentiviral shRNA.
(D) Summary of recordings (examples in B and C) showing that peak ITRPM7 is reduced by shRNA knockdown of TRPM7 to 16% of control (CNTRL) (ITRPM7
at +100mV; ±SEM, n = 4).
(E) TRPM7 knockdown Jurkat cells are resistant to Fas-induced cell death. Immunoblots of cleavedPARP and a-tubulin in lysates of unstimulated (untx, n = 2) and
Fas-stimulated (anti-Fas, n = 3) Jurkat cells infected with control (blue) and TRPM7-specific shRNA (orange). The PARP cleavage index (average ± SEM) (bottom)
was calculated using the densitometric ratio of cleaved PARP signal over a-tubulin.
(F) TRPM7 knockdown Jurkat cells were not resistant to etoposide-induced cell death (25 mM, 8 hr). Bottom shows PARP cleavage index of etoposide-induced
apoptosis in Jurkat cells infected with the control and M7shRNA-expressing lentivirus.
(G) Fas sensitivity of LN18 cells expressing variants of TRPM7 as evaluated by dose-dependent increase in percentage of LN18 cells with active caspase-3 (±SD,
n = 3). The transfected variants include WT, nonconducting pore mutant (pm), and the kinase-dead K1646A (KA) mutant. Cells were stimulated with anti-Fas
antibody for 3 hr prior to fixation and immunostaining. The percentages of apoptotic cells were calculated as cells exhibiting activated caspase-3 divided by
transfected (RFP+) cells.
(H) Apoptosis induced by increasing concentrations of anti-Fas antibody in 293T cells cotransfected with TRPM7 variants. Fas-induced apoptosis was assessed
by quantifying PARP cleavage in cell lysates. Data points represent the corresponding average PARP-cleavage indices (±SEM, n = 4).
See also Figure S2 and Movie S1.
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Fas Signaling Regulates TRPM7 by Caspase CleavageFas-stimulated apoptosis throughout the effective range of the
agonist antibody concentration. We also evaluated WT and
mutant T cell sensitivity to plate-bound anti-Fas agonist antibody
and confirmed the relative resistance of Trpm7/ T cells to Fas-
induced apoptosis (Figure 1D). These findings are consistent
with cell viability assays in response to Fas stimulation (Fig-
ure S1C). The cell surface levels of Fas receptor on activated
Trpm7/ T cells were equal to WT T cells (Figure 1E).
Resistance to Fas-Induced Cell Death after Depletion
of TRPM7 in Jurkat Cells
Next, we evaluated Fas-induced cell death in the human Jurkat
T cell leukemia cell line using an RNAi approach. To deplete
TRPM7 levels in Jurkat cells, we generated a lentivirus thatDevelopmexpresses a small hairpin RNA directed against the TRPM7
mRNA (LV-M7shRNA) and also marks the transduced cell
through bicistronically expressed GFP. The resulting depletion
of TRPM7mRNAwas evident by quantitative real-time PCR (Fig-
ure 2A). Patch-clamp recordings of GFP+ cells confirmed an
10-fold reduction in the whole-cell TRPM7 current, ITRPM7
(Figures 2B–2D). We measured apoptosis in Jurkat cells by
immunoblotting the lysates for cleaved Poly-ADP ribose poly-
merase (PARP), a terminal substrate of executioner caspases.
Jurkat cells transduced with LV-M7shRNA were resistant to
Fas-receptor-dependent cell death (Figure 2E), but not to etopo-
side-induced cell death (Figure 2F), which relies on a different
signaling mechanism for initiating apoptosis (Lowe et al.,
1993). The sensitivity of Fas-induced apoptosis in Jurkatental Cell 22, 1149–1162, June 12, 2012 ª2012 Elsevier Inc. 1151
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Figure 3. Fas Signaling Induces a Rapid Cleavage of TRPM7 in a Caspase-Dependent Manner
(A) LN18 cell Fas receptors were stimulated for the indicated times, and TRPM7 was immunoprecipitated using anti-TRPM7 (C47, raised against the TRPM7
kinase domain). The cleaved 42 kDa carboxy-terminus (CT) fragment is faintly detectable after 1 hr but robust at 3 hr after Fas receptor stimulation. Bottom panels
present activation of caspase-3 as detected by immunoblotting with antibody specific for cleaved caspase-3 and actin
(B) Detection of the 42 kDa TRPM7 carboxy-terminal cleavage fragment using amousemonoclonal antibody, N74/25, directed against the C-terminal amino acid
sequence 1,817–1,863. The C-47 rabbit polyclonal antibody detected the fragment in the immunoblot. Bottom panels illustrate cleavage of PARP as detected by
a cleaved PARP-specific antibody.
(C) Cleavage of TRPM7, as detected by appearance of the 42 kDa cleavage product, is abrogated when cells are treated with ZVAD-FMK (pan-caspase inhibitor)
during 3 hr Fas receptor stimulation (same conditions used in A). Bottom shows activation of caspase-3 in the same samples.
(D) Fas-induced cleavage of TRPM7 yields an 160 kDa N-terminal fragment (anti-M7 antibody generated against aa 1,277–1,380). Untreated and Fas-stim-
ulated LN18 cells stably expressing N-terminal SBP-tagged TRPM7 were used to pull down M7 complexes using streptavidin beads prior to immunoblotting.
(E) Top shows in vitro activation of caspase-8 and caspase-3 in Jurkat S100 cytosolic extracts by addition of cytochrome c and dATP. In indicated samples,
caspase-8 and caspase-3 were immunodepleted from the cytosolic extracts prior to activation by cytochrome c and dATP. Lower panel presents in vitro
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Developmental Cell
Fas Signaling Regulates TRPM7 by Caspase CleavageT cells to depletion of TRPM7 supports the view that the defec-
tive Fas receptor signaling in Trpm7/ T cells is not a result of
a developmental defect. These findings strongly suggest that
TRPM7 participates in Fas receptor signaling.
TRPM7 Potentiates Fas Receptor-Induced Activation
of Caspase-3 in a Channel-Dependent and Kinase
Activity-Independent Manner
For mechanistic insight, we set out to distinguish the relative
contributions of the TRPM7 pore from its kinase activity in Fas
receptor signaling. Because we failed to express TRPM7 vari-
ants with substantial efficiency in Jurkat cells, we screened for
Fas-sensitive cell lines that enable the ectopic expression of
TRPM7, a protein that is difficult to express transiently in most
cell lines. LN18, an adherent human glioblastoma cell line, can
express full-length variants of TRPM7 at an efficiency of 5%–
10%. In these cells, Fas receptor signaling can be evaluated
through immunofluorescent detection of the cleaved caspase-
3 (active caspase-3), 3 hr after Fas stimulation (Figure S2E).
Additional characterization of LN18 cells showed that these cells
belong to the type 2 category of Fas-sensitive cells reliant on the
mitochondrial amplification loop for the efficient completion of
apoptosis. LN18 cells release cytochrome c in response to Fas
activation, and ectopic expression of Bcl-2 reduces their sensi-
tivity to Fas-induced apoptosis as detected by the percentage
of cells with active caspase-3 (Figure S2A). Next, we confirmed
that LN18 cell Fas sensitivity is affected by TRPM7 function.
Transfection of LN18 cells with siRNA duplexes directed against
the TRPM7mRNA (M7siR#3) results in a substantial depletion of
TRPM7 mRNA as measured by quantitative real-time PCR (Fig-
ure S2B). Testing these cell populations for Fas-induced
apoptosis showed that depletion of TRPM7 in LN18 cells leads
to reduced sensitivity to Fas-induced apoptosis as detected by
the percentage of cells with active caspase-3 (Figure S2C).
Next, we evaluated the Fas sensitivity of LN18 cells. TRPM7
variants were expressed through a previously described
plasmid, Red-pTracer-CAG (Brauchi et al., 2008), that bicistroni-
cally encodes monomeric RFP in transfected cells (Figure S2D).
We confirmed that RFP+ cells also expressed the encoded
TRPM7 variant (Figure S2D). When compared to LN18 cells
transfected with vector alone, expression of WT TRPM7 (M7-
WT) augments the activation of caspase-3 asmeasured 3 hr after
Fas receptor stimulation (Figures 2G and S2E). In contrast, the
ectopic expression of a TRPM7 variant with a mutant (noncon-
ducting) pore (M7-pm) (Krapivinsky et al., 2006) does not affect
caspase-3 activation. A TRPM7 variant with the amino acid
substitution, K1646A, renders the kinase inactive (Matsushita
et al., 2005), but it augmented Fas receptor signaling in amanner
comparable to WT TRPM7 (Figure 2G). Similar results were ob-cleavage of immunopurified TRPM7 by S100 extracts shown in top panel. TRP
terminus. Note the loss of full-length TRPM7 and emergence of the 42 kDa kinas
(F) In vitro caspase-8 cleavage of TRPM7 is blocked by amino acid substitutio
35S-labeled TRPM7 C-terminal polypeptide.
(G) The TRPM7(D1510A) variant is not cleaved in vivo in response to Fas stimulat
WT and TRPM7 (DA). Anti-T7 immunoprecipitates were probed for cleavage by im
fragment.
(H) An illustration showing the dissociation of the TRPM7 channel and kinase dom
site in mouse, human, and sheep is shown.
See also Figure S3.
Developmtained in 293T cells, which provide an avenue for high transfec-
tion efficiency. Because 293T cells express very low levels of Fas
and are insensitive to Fas stimulation, the assay was carried out
by sequentially expressing the Fas receptor and the TRPM7 vari-
ants. In this experiment, the Fas-induced apoptosis was
measured by quantitative immunoblotting of cleaved PARP
and a-tubulin (Figures 2H and S2G). The cleavage of PARP has
been quantified by deriving the densitometric ratio of cleaved
PARP and a-tubulin detected in the same immunoblot. These
results show that ectopic expression of TRPM7-WT and
TRPM7-KA, but not TRPM7-pm, potentiates Fas-induced cell
death (Figure 2H). The expression of TRPM7 variants and Fas
in these cells is shown in Figure S2H. Ectopic expression of
M7-WT or M7-pm did not affect the expression or localization
of coexpressed Fas (Figure S2H; data not shown). Interestingly,
ectopic expression of TRPM7 in LN18 cells also potentiates
TRAIL-induced apoptosis but does not have a substantial effect
on apoptosis induced by exposure to UV light, etoposide, and
staurosporine (Figure S2F). Overall, these results indicate that
the role of TRPM7 in extrinsic apoptosis is dependent on the
channel activity of TRPM7 and does not depend on its kinase
activity.
TRPM7 Is Cleaved by a Caspase in Response to Fas
Receptor Stimulation
Although TRPM7 current (ITRPM7) is readily detectable in most
cells, the TRPM7 protein is expressed at very low levels and is
biochemically detectable by immunoblotting only after enrich-
ment through immunoprecipitation. Compared to unstimulated
LN18 cells, the Fas-stimulated LN18 cells contain a 40–42 kDa
TRPM7 fragment that is detectable by immunoblotting with an
antibody raised against the carboxy-terminal kinase domain of
TRPM7 (Figure 3A). The emergence of this fragment is evident
1 hr after Fas ligation (Figures 3A and S3) and peaks 3 hr after
Fas ligation. To rule out artifacts due to antibody cross-reactivity,
we confirmed the cleavage using a different TRPM7 antibody for
immunoprecipitation of endogenous TRPM7 (Figure 3B). When
LN18 cells were treated with a pan-caspase inhibitor, ZVAD-
fmk, the cleavage was abolished, indicating a dependence on
caspase activity (Figure 3C). The anti-TRPM7 antibodies used
in these immunoblots are reactive to the extreme carboxy-
terminal amino acid sequence of TRPM7, indicating that the
42 kDa fragment of TRPM7 retains the carboxyl terminus kinase
domain of TRPM7. We also generated a stable cell line of LN18
expressing a TRPM7 variant that was tagged at the N terminus
with streptavidin-binding peptide (SBP). After Fas-induced
TRPM7 cleavage, we pulled down the N-terminal fragment by
using streptavidin beads and immunoblotted TRPM7 using
a rabbit polyclonal antibody that was generated against theM7 was detected by anti-M7 antibody directed against the TRPM7 carboxy-
e domain upon cleavage.
ns D1510A and S1511E. Mutation S1511A does not prevent cleavage of the
ion. LN18 cells were transfected with C-terminal T7-tagged variants of TRPM7
munoblotting with anti-T7 antibody to detect the 42 kDa C-terminal cleavage
ains after cleavage at D1510. The proximal sequence of the TRPM7 cleavage
ental Cell 22, 1149–1162, June 12, 2012 ª2012 Elsevier Inc. 1153
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Fas Signaling Regulates TRPM7 by Caspase CleavageTRPM7 amino acid sequence 1,277–1,380 (N-terminal to the
cleavage site D1510). This analysis shows the generation of an
160 kDa N-terminal fragment of TRPM7 in Fas-stimulated cells
(Figure 3D).
Caspase-8, as well as Caspase-3, Contributes to the
Cleavage of TRPM7
Because TRPM7 cleavage was detectable 1 hr after Fas stimu-
lation, we reasoned that the cleavage was mediated by cas-
pase-8, the apical or initiator caspase during Fas-induced
apoptosis. Inhibitors of caspase-8, however, are not useful in illu-
minating this aspect because inhibition of the initiator caspase
prevents the activation of all subsequent caspases. To gain
insight, we took advantage of a cell-free system that allows the
activation of caspases in vitro through the addition of cyto-
chrome c and dATP to cytosolic extracts (Li et al., 1997; Liu
et al., 1996). Although this type of activation is initiated through
the activation of apoptosome (Apaf-1-cytochrome c-caspase-
9 complex), it leads to a comprehensive activation of caspases
(including caspase-8) through a physiologically relevant, albeit
in vitro, process that does not involve Fas signaling (McStay
et al., 2008). We investigated the effect of immunodepletion of
caspase-8 and caspase-3 on the in vitro cleavage of TRPM7
by such cytosolic preparations. When caspases in the cytosolic
S100 preparations from Jurkat cells were activated by the addi-
tion of cytochrome c and dATP, the activated (cleaved) forms of
caspase-8 and caspase-3 were readily detected (Figure 3E). In
contrast, immunodepletion of caspase-3 and caspase-8 prior
to activation by cytochrome c and dATP resulted in near-
complete loss of these caspases in the activated preparations
(Figure 3E). We then used these preparations to cleave immuno-
purified TRPM7 in vitro. As shown in Figure 3E (bottom),
cleavage of TRPM7 is reduced by immunodepletion of cas-
pase-8. However, we also find a similar reduction upon immuno-
depletion of caspase-3, indicating that caspase-8 contributes to
TRPM7 cleavage but is not the exclusive mediator of TRPM7
cleavage. In the experiments discussed below, the in vitro
cleavage of TRPM7 by caspase-8 is also demonstrated using
purified caspase-8 (Figure 3F).
TRPM7 Is Cleaved at D1510, Releasing the Kinase
Domain
Based on the molecular size of the TRPM7 carboxy-terminal
cleavage fragment (40 kDa), we reasoned that the TRPM7
cleavage site was approximately 350 aa upstream of the
terminal amino acid and identified putative sequences that
could serve as caspase substrates. The residue D1510 (mouse
TRPM7 sequence) is flanked by a sequence that is congruent
with the experimentally determined substrate selectivity of cas-
pase-8 (Mahrus et al., 2008; Pop and Salvesen, 2009). In an
in vitro assay of TRPM7 cleavage, using an 35S-labeled
58 kDa C-terminal fragment of TRPM7 as the substrate, we
confirmed that the caspase-8-mediated cleavage generates
a 40–42 kDa C-terminal fragment (Figure 3F). Substitution of
D1510 to an alanine (D1510A) abrogated the cleavage, suggest-
ing that the cleavage occurred at D1510 (Figure 3F). Because
the adjoining residue, S1511, is known to be autophosphory-
lated by TRPM7 kinase (Matsushita et al., 2005), we evaluated
the effect of a phosphomimetic substitution, S1511E, and its1154 Developmental Cell 22, 1149–1162, June 12, 2012 ª2012 Elsevconverse substitution, S1511A. The S1511E substitution abol-
ished TRPM7 cleavage, but S1511A was cleaved efficiently
(Figure 3F). These results indicate that TRPM7 is cleaved early
during Fas receptor stimulation at D1510, resulting in the disso-
ciation of TRPM7’s kinase domain from its channel domain. The
results from the S1511 substitutions suggest a possible role for
phosphorylation in the regulation of caspase-dependent
TRPM7 cleavage, with the important caveat that caspase-8
strongly prefers small uncharged residues in this position (P10)
(Pop and Salvesen, 2009). The cleavage of TRPM7 at D1510
is also demonstrated through the analysis of ectopically ex-
pressed TRPM7 variants containing a carboxy-terminal T7 im-
munoepitope tag (Figure 3G). In contrast to WT TRPM7, the
TRPM7 variant with a D1510A mutation is not cleaved in
response to Fas stimulation of LN18 cells (Figure 3G). These
results indicate that Fas receptor signaling results in the
cleavage of TRPM7.
Taken together, these data lead us to conclude that in
response to Fas signaling, TRPM7 undergoes a caspase-medi-
ated cleavage at D1510 to generate two distinct proteins: the
TRPM7 channel and the TRPM7 kinase. Based on the observa-
tion that the cleavage is detectable in the early phase of
apoptosis (1 hr after Fas stimulation), the immunodepletion
experiments, and in vitro cleavage of TRPM7 by caspase-8,
we propose that the cleavage is initiated by caspase-8 but sus-
tained by downstream caspases during the entire process of
apoptosis. In contrast, caspase-8 substrates like Bid (Li et al.,
1998) and RIPK3 (Kaiser et al., 2011; Oberst et al., 2011) are
thought to be cleaved selectively by caspase-8 during extrinsic
apoptosis. The caspase-dependent cleavage of TRPM7 is illus-
trated in Figure 3H.
The Dissociated Kinase Domain of TRPM7 Retains
Phosphotransferase Activity but Does Not Potentiate
Fas Receptor Signaling
The cleavage of TRPM7 at D1510 releases the 42 kDa polypep-
tide containing the kinase domain (M7kin42) from the
membrane-resident channel. As discussed earlier, the partici-
pation of TRPM7 in Fas-induced apoptosis is dependent on
the channel activity, and not the kinase activity. In accord
with this, we show that although the released 42 kDa fragment
retains kinase activity, it does not modulate Fas-induced
apoptosis. We tested whether the released kinase is capable
of phosphotransferase activity by conducting in vitro kinase
assays with ectopically expressed FLAG-tagged M7kin42.
Autophosphorylation activity of M7kin42 in the presence of
33P-labeled ATP was evaluated by autoradiography, and
M7kin42 was found to be active (Figure 4A). In contrast,
M7kin42GV, a variant of the M7 kinase domain with a targeted
substitution (G1619V) in the ATP-binding pocket, showed
minimal autophosphorylation, indicating that the phosphoryla-
tion was not a result of an endogenous kinase in the immuno-
precipitate (Figure 4A). Both variants of M7kin42, WT and GV,
are expressed at comparable levels (Figures 4A and S4A).
LN18 cells transfected with M7kin42-WT or M7kin42-GV vari-
ants showed no appreciable difference in the Fas-induced acti-
vation of caspase-3 (Figures 4B and S4B). Next, we tested
whether the cleavage of TRPM7 is necessary for its participa-
tion in Fas-induced apoptosis.ier Inc.
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Figure 4. The Cleavage-Resistant Variant
TRPM7(D1510A) Does Not Participate in
Fas-Induced Apoptosis
(A) Phosphotransferase activity of FLAG-tagged
M7kin42 and the kinase-dead variant, M7kin42
(GV), evaluated by in vitro autophosphorylation in
the presence of 33P-labeled ATP. Expression
levels were confirmed by immunoblotting (IB) with
anti-FLAG.
(B) Fas sensitivity of LN18 cells ectopically ex-
pressing the 42 kDa kinase fragment M7kin42 and
its kinase-inactive variant, M7kin42(GV), in
response to increasing concentrations of anti-Fas
antibody (±SD, n = 2). clv, cleavage.
(C) Fas sensitivity of LN18 cells expressing TRPM7
variants as measured by the dose-dependent
increase in the percentage of LN18 cells with
active caspase-3 (WT, TRPM7-D1510A [DA,
cleavage resistant], TRPM7-DK [cleaved], and
TRPM7-DK-pm [cleaved, pore mutant]; ± SD,
n = 3). Cells were stimulatedwith anti-Fas antibody
for 3 hr prior to fixation and immunostaining.
Apoptotic cells were calculated as cells exhibiting
activated caspase-3 of all transfected (RFP+)
cells.
(D) Apoptosis induced by increasing concentra-
tions of anti-Fas antibody in 293T cells co-
transfected with TRPM7 variants; Fas-induced
apoptosis assessed by quantifying PARP
cleavage in cell lysates. The graph shows average
PARP cleavage indices (±SEM, n = 4).
(E) Ratiometric measurement of intracellular Ca2+
in LN18 cells transfected with indicated TRPM7
variants and loaded with fura-2 AM dye.
See also Figure S4.
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Fas Signaling Regulates TRPM7 by Caspase CleavageThe Cleavage of TRPM7 at D1510 Is Critical for the
Potentiation of Fas-Induced Apoptosis by TRPM7
To evaluate the role of cleavage in extrinsic apoptosis, we inves-
tigated the ability of TRPM7 to potentiate Fas-induced apoptosis
when the critical residue D1510 is mutated (TRPM7-D1510A or
simply M7DA). We also evaluated the ability of the cleaved
TRPM7 channel domain in this assay. Because the cleaved
TRPM7 channel lacks the kinase domain, the TRPM7 variant
truncated at D1510 is referred to as TRPM7-DK or M7-DK. We
expressed the empty vector, M7-WT, M7-DA (TRPM7-D1510A
mutant), M7DK (TRPM7 truncated at D1510), and M7DK-pm
(nonconducting pore mutation in truncated TRPM7) in LN18
cells. Caspase cleavage-resistant M7D1510A mutant did not
potentiate Fas-induced apoptosis, indicating that cleavage
was necessary for this effect (Figures 4C and S4C). The cleaved
channel greatly potentiated caspase-3 activation when the pore
was functional (M7-DK), but not when the pore was mutated
(M7-DK-pm) (Figures 4C and S4C). Similar results were obtained
in 293T cells coexpressing theM7 variants and Fas, asmeasured
by PARP cleavage (Figure 4D). Expression of M7DK but not
M7D1510A or M7DK-pm increased the Fas sensitivity of 293T
cells coexpressing the Fas receptor. Representative immuno-
blots of cleaved PARP and a-tubulin are shown in Figure S4D.
The expression of TRPM7 variants and the Fas receptor is shown
in Figure S4E. These results show that the critical TRPM7 func-Developmtion in Fas receptor signaling is dependent on cleavage-medi-
ated modulation of TRPM7 channel activity but is not due to
cellular Ca2+ overload. Although TRPM7 is a cationic channel
permeant to Ca2+, the inward conductance of TRPM7 at physio-
logical membrane potential does not lead to a substantial influx
of Ca2+ in cells expressing ectopic TRPM7 (Figure 4E). The
precise mechanism by which TRPM7 modulates TRPM7 is not
clear at this point but is likely to involve dynamic changes in
subcellular microdomains of Ca2+, Mg2+, or Zn2+ during death
receptor signaling.
Cleavage of TRPM7 at D1510 Increases TRPM7
Currents
The cleavage of TRPM7 at D1510 dissociates the 40 kDa kinase
domain from the 172 kDa ion-conducting pore (M7-DK). To eval-
uate the effect of cleavage on TRPM7 channel conductance, we
expressed TRPM7 variants in CHO cells. These cells have very
low endogenous TRPM7 currents and allow electrophysiological
resolution of ITRPM7 elicited by ectopically expressed TRPM7
variants without excessive overexpression. ITRPM7 characteristi-
cally develops over time after membrane rupture, a process
commonly referred to as ‘‘break-in’’ during patch-clamp
recording. All functional TRPM7 variants exhibited similar
current-voltage relationships and were expressed at compa-
rable levels in CHO cells (Figure S5A). We analyzed the meanental Cell 22, 1149–1162, June 12, 2012 ª2012 Elsevier Inc. 1155
Figure 5. Cleavage of TRPM7 at D1510 Potentiates TRPM7 Currents
(A) ITRPM7 developed gradually with intracellular perfusion in CHO cells transfectedwith different TRPM7 variants. Current densities at +100mV are plotted against
time after break-in.
(B) Box chart of TRPM7 maximum outward current densities at 50 s (left) and 500 s (right) after break-in (measured at +100mV). Statistics pertaining to TRPM7
currents are shown as Box (±SEM), vertical bars (5th95th percentile), and data overlap.
(C) Maximum inward current densities (measured at 100mV).
(D) Box chart of inward current densities obtained at 100mV. See also Figure S5.
(E) The effect of ectopic expression of TRPM7 variants in KO T cells. The percentage of ANXA5+ T cells was quantified by flow cytometry (±SD, n = 3), and
representative flow cytometry histograms are shown. The gating scheme is clarified in Figure S5.
(F) The bar graph shows quantitation of results as the percentage of ANXA5+ cells (±SD, n = 3) in T cells ectopically transfected with the indicated TRPM7 variants.
See also Figure S5
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Fas Signaling Regulates TRPM7 by Caspase Cleavagecurrent density in transfected CHO cells at +100mV (outward
current, Figures 5A and 5B) and at 100mV (inward current,
Figures 5C and 5D). In cells expressing M7-WT the current
increases to a mean current density of 250 pA/pF after 50 s
and to 600 pA/pF after 500 s, whereas M7-DK currents develop
faster and exhibit mean current densities that are significantly
higher (720 pA/pF after 50 s and 925 pA/pF after 500 s). In
contrast, cells transfected with M7-pm lack substantial current
after break-in (Figures 5A and 5B, blue). TRPM7-D1510A
(M7-DA) current densities are somewhat lower, but not signifi-
cantly different than WT. In agreement with a previous report
by Schmitz et al. (2003), point mutations that inactivated the
kinase did not affect TRPM7 channel activity (Figures S5B and
S5C). Overall, these data indicate that after the cleavage of
TRPM7 by caspase-8, higher currents are achieved when
compared to full length, uncleaved TRPM7.1156 Developmental Cell 22, 1149–1162, June 12, 2012 ª2012 ElsevWe also confirmed that ITRPM7 is expressed in LN18 cells. A
Mg2+-inhibitable current develops in a time-dependent manner
(Figure S5D) and shows the signature current-voltage relation-
ship of ITRPM7. Furthermore, we show that this current shows
pharmacological sensitivity identical to that of TRPM7. It is in-
hibited by 0.5mM2APB but fully reactivated by 2mM2APB (Fig-
ure S5E). ITRPM7 in LN18 cells is also activated by 10 mM NH4Cl
(data not shown).
Reconstitution of TRPM7 Variants in Trpm7–/– Mouse
T Cells
Next, we evaluated the effect of reconstituting TRPM7 variants in
Trpm7/ T cells. In comparison to WT T cells, the vector-trans-
fected Trpm7/ T cells were less than half as sensitive to FAS
stimulation (Figures 5E, 5F, and S5D). Surprisingly, the Trpm7/
T cells transfected with TRPM7-WT and TRPM7-DK exhibitedier Inc.
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Fas Signaling Regulates TRPM7 by Caspase Cleavagespontaneous (without FAS stimulation) apoptosis. This effect
was not seen in cells expressing TRPM7-pm and TRPM7-DA,
suggesting that Trpm7/ T cells are capable of apoptosis but
are restrained due to a lack of TRPM7 channel activity. Overex-
pression of competent TRPM7 variants likely leads to apoptosis
due to the presence of active caspases in proliferating T cells
(Kennedy et al., 1999; Leverrier et al., 2011; Siegel, 2006).
Because TRPM7-pm and TRPM7-DA do not result in apoptosis,
the results support the conclusion that the cleavage of TRPM7 at
D1510 and the consequent channel activity plays an important
role in FAS-induced apoptosis.
TRPM7 Acts Upstream of Cytochrome c Release during
Fas-Induced Apoptosis
For mechanistic insight and to pinpoint the process that is regu-
lated by TRPM7 during Fas-induced apoptosis, we first deter-
mined whether TRPM7 acts upstream or downstream of cyto-
chrome c release from mitochondria in LN18 cells. We
generated a stable cell line, LN18 (CytC-GFP), expressing cyto-
chrome c-GFP in the LN18 background. In this cell line, cyto-
chrome c-GFP localizes predictably to the mitochondria and is
released from the mitochondria in response to Fas stimulation
(Movie S1). When these cells are transfected with siRNA target-
ing TRPM7, the release of cytochrome c-GFP from the mito-
chondria is abrogated (Figures 6A and 6B). After 180 min of
Fas stimulation, 37% of the cells transfected with control siRNA
released cytochrome c. In contrast only 5% of the cells trans-
fected with TRPM7 siRNA released cytochrome c-GFP (Fig-
ure 6B). A similar difference was seen at 240 min of Fas stimula-
tion (Figure 6B). These data indicate that TRPM7 acts upstream
of cytochrome c release in type 2 cells. We also evaluated the
effect of knocking down TRPM7 in SKW6.4 cells, a prototypical
type 1 Fas-sensitive cell line that does not depend on the mito-
chondrial amplification loop to execute Fas-induced apoptosis
(Schmitz et al., 1999). The reduction in TRPM7 levels upon trans-
fection of TRPM7-targeting siRNA is shown through immunopre-
cipitation and immunoblotting of TRPM7 (Figure S6A). SKW6.4
cells with reduced TRPM7 levels show significantly reduced
sensitivity to Fas-induced apoptosis (Figure S6B).
TRPM7 Does Not Regulate Formation of the DISC
We analyzed the DISC in SKW6.4 cells with knocked down
TRPM7 in consideration of the hypothesis that TRPM7 regulates
the assembly of the DISC upon Fas stimulation. This was done
by immunoprecipitating the Fas receptor from lysates generated
at specific time points after Fas stimulation and immunoblotting
for the two key components of DISC: procaspase-8 and FADD.
These results, shown in Figure 6C, do not support the hypothesis
that TRPM7 regulates the assembly of DISC. After 10 min of Fas
stimulation, both cell populations (control siRNA and TRPM7
siRNA-treated) show recruitment of FADD and procaspase-8.
The composition of DISC at 60 min shows modest differences
in the levels of procaspase-8, but our results did not allow us
to conclude that this difference was statistically significant. Inter-
estingly, the activity of caspase-8 at the same time points shows
modest but significant differences (Figure 6D). These data indi-
cate that although TRPM7 does not regulate the assembly of
DISC, it influences the processing of caspase-8 in the subse-
quent steps. Fas receptor transmits apoptotic as well as survivalDevelopmsignals (Peter et al., 2007). The process by which the cellular
context dictates whether Fas signaling results in apoptosis or
nonapoptotic signals is not well understood, but internalization
and compartmentalization of the DISC have been proposed as
critical events driving the transmission of apoptotic signal (Schu¨-
tze et al., 2008). In SKW6.4 cells transfected with TRPM7 siRNA,
we observed that decreased sensitivity to apoptosis (Figures 6E
and S6B) was also accompanied by activation of the MAPK
pathway, as detected by the presence of phosphorylated Erk1/
Erk2 in cell lysates (Figure 6E). We then considered the possi-
bility that SKW6.4 cells with reduced TRPM7were compromised
in the process of Fas receptor endocytosis after Fas stimulation,
favoring the transmission of nonapoptotic signals downstream
of Fas.
TRPM7 Regulates Internalization of Fas following
Receptor Stimulation
Internalization of the Fas receptor in SKW6.4 cells following
receptor stimulation has been described previously (Algeciras-
Schimnich et al., 2002; Siegel et al., 2004). We used an anti-
Fas agonist antibody conjugated to a fluorophore (Alexa 568)
to stimulate the Fas receptor and observe its subsequent inter-
nalization. The staining of the Fas receptor (on the cell surface)
with this antibody is detectable after 15 min of incubation in
cell culture conditions. As shown in Figure S6C, internalization
follows this receptor engagement, and 75% of the SKW6.4 cells
can be seen to have internalized the Fas receptor after 1 hr of
stimulation (Figures 6F and 6G). In contrast, the SKW6.4 cells
that are transfected with TRPM7 siRNA do not exhibit Fas inter-
nalization at a comparable level; only 30% of the cells show Fas
internalization (Figures 6F and 6G). We carried out the same
experiment with LN18 cells. In the case of LN18 cells, the Fas
receptor levels are lower, and their distribution in the plasma
membrane was strikingly polarized. Nevertheless, internalization
is readily detectable in LN18 cells transfected with control
siRNA. Again, the cells transfected with TRPM7 siRNA show
considerably reduced incidence of Fas receptor internalization
after 1 hr of stimulation (Figures 6H and 6I). A time course of inter-
nalization in the LN18 cells is shown in Figure S6D as a montage
of images acquired between 15 min and 1 hr of Fas stimulation.
The punctate pattern of internalized Fas is not due to redistribu-
tion of the Fas receptor within the plasmamembrane—the punc-
tae are indeed inside the cells. This is demonstrated through the
acquisition of confocal images along the vertical axis (z stack of
images) of cells transfected with control siRNA and TRPM7
siRNA. These images are shown as a combined movie (Movie
S2). Overall, these results clearly show that TRPM7 participates
in regulating the internalization of Fas receptor.
Lung Inflammation and Airspace Enlargement in Aged
TM7–/– Mice
TM7/ mice show a pathophysiological similarity to the mice in
which the Fas receptor is selectively deleted in T cells (TFas/
mice). In contrast to the phenotype of global deletion of Fas,
which results in lymphoproliferative, autoimmune pathology in
young animals (Watanabe-Fukunaga et al., 1992), the selective
deletion of Fas in T cells leads to lymphopenia and a high inci-
dence of pulmonary inflammation and lung-tissue damage
upon aging (Hao et al., 2004). Similarly, the lungs of 13- toental Cell 22, 1149–1162, June 12, 2012 ª2012 Elsevier Inc. 1157
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Figure 6. TRPM7 Regulates Internalization of Fas Receptor
(A) LN18 cells stably transfectedwith CytC-GFPwere transfectedwith indicated siRNA. Release of cytochrome cwas evaluated upon Fas stimulation at indicated
time points. Red arrowheads mark the cells that have released CytC-GFP from the mitochondria.
(B) Quantitation of cytochrome c release is shown as percentage of cells with released CytC-GFP at indicated time points after Fas stimulation.
(C) Top shows analysis of DISC formation at indicated time points after Fas stimulation in SKW6.4 cells. Immunoblots show the levels of Fas, FADD, and caspase-
8 in isolated DISC. Bottom shows levels of cleaved PARP and a-tubulin in the lysates of Fas-stimulated SKW6.4 cells at corresponding times shown in the top
panel.
(D) Caspase-8 activity in caspase-8 immunoprecipitates isolated from Fas-stimulated SKW6.4 cells at indicated time points. The y axis shows relative lumi-
nescence units (RLU) detected upon cleavage of luminogenic caspase-8 substrate in presence of luciferase enzyme.
(E) Immunoblots show the presence of phosphor-Erk1/Erk2 in the lysates of unstimulated and Fas-stimulated (1 hr) SKW6.4 cells.
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Fas Signaling Regulates TRPM7 by Caspase Cleavage15-month-old TM7/ mice exhibit pulmonary inflammation and
emphysema. Hematoxylin and eosin staining (H&E) of lung
tissues revealed alveolar damage and significant enlargement
of alveolar airspaces, similar to the histopathology of emphy-
sema (Figure 7A). We quantified the enlargement of alveolar
airspaces through morphometric analysis (Jacob et al., 2009)
of H&E lung slices of WT and TM7/ as briefly illustrated in Fig-
ure S7. A comparison of mean linear intercept (MLI) and the
statistical moments (D0, D1, and D2) of the equivalent diameter
(deq) between the airspaces of WT and T
M7/ mice lungs are
shown as statistical box charts in Figure 7B. Antibody staining
using anti-CD3 (Figure 7C, left), B220 (Figure 7C, right), and
Ly6G (Figure 7D) documents the increased infiltration of
T cells, B cells, and neutrophils into the lungs of aged TM7/
mice (Figure 7E). We did not observe a significant difference
between the lungs of young mice, suggesting that pulmonary
inflammation and emphysema seen in the TM7/ mice are age
dependent. This is remarkably similar to the phenotype of mice
in which Fas was selectively deleted in T cells. The selective
deletion of Fas in T cells leads to lymphopenia without obvious
pathology in young mice, but a high incidence of pulmonary
inflammation and lung-tissue damage upon aging (Hao et al.,
2004). This phenotype is distinct from global deletion of Fas,
which results in an autoimmune pathology that is evident in
young animals (Watanabe-Fukunaga et al., 1992).
DISCUSSION
We demonstrated that TRPM7 is cleaved by caspase-8 at
D1510, dissociating the kinase from the ion-conducting pore.
The cleaved channel exhibits substantially higher ITRPM7 and
potentiates Fas receptor signaling. In contrast, neither the
cleaved kinase domain nor the cleavage-resistant TRPM7
D1510A mutant potentiates this pathway. Cleavage-induced
current enhancement is specific to D1510 because TRPM7 trun-
cated at other sites within the kinase domain does not elicit an
increase in currents (Matsushita et al., 2005; Schmitz et al.,
2003). The cleavage-induced augmentation of TRPM7 channel
activity is not due to inactivation of its kinase. Cleavage elicits
two distinct functional proteins (channel and kinase) that can
now differentially localize. These data indicate that TRPM7
cleavage is an important regulatory step for TRPM7 function in
Fas receptor signaling. In cells where TRPM7 levels have been
reduced substantially through siRNA treatment, the Fas receptor
is not internalized normally in response to receptor stimulation. In
these cells, the reduction in their sensitivity to Fas-induced
apoptosis correlates with an increase in activation of MAPK
pathway, a nonapoptotic signaling route for Fas signaling.
Finally, in accord with the cellular phenotype, the TM7/ mice(F) The confocal images show internalization of Fas in SKW6.4 cells after Fas sti
mergers of red channel (Alexa 568) and differential interference contrast (DIC) (sho
Fas, and white arrowheads mark the cells with Fas at the plasma membrane (no
(G) The bar graphs show the percentage of cells with internalized Fas in SKW6.4
(H) Confocal images show internalization of Fas in LN18 cells after Fas stimulatio
568-labeled cells in fluorescence and DIC; merged images show Alexa 568 in
arrowheads mark the cells with internalized Fas, and white arrowheads mark the
(I) The bar graphs show the percentage of LN18 cells with internalized Fas after
See also Figure S6 and Movie S2.
Developmshow a distinct pathophysiological similarity to the mice in which
Fas is selectively deleted in T cells (TFas/ mice).
Because many TRP channels have emerged as regulators of
cell death (Aarts et al., 2003; Hara et al., 2002), inflammation
(Barbet et al., 2008; Link et al., 2010; Sumoza-Toledo and Pen-
ner, 2011; Yamamoto et al., 2008), and pain (Basbaum et al.,
2009), this study raises the possibility that in these roles, TRP
channels are regulated through caspase-mediated cleavage
events. The findings thus offer an avenue of research to guide
pharmacological intervention of multiple diseases.
EXPERIMENTAL PROCEDURES
Reagents and detailed methods are in the Supplemental Experimental
Procedures.
Mice
Mice were bred and maintained according to guidelines and procedures
approved by the Institutional Animal Care and Use Committee.
Cell Culture
HEK293, LN18, Jurkat (clone E6-1), CHO, and SKW6.4 cell lines were obtained
from American Type Culture Collection (ATCC). Fas receptor stimulation for
indicated times was with anti-human Fas antibody (clone CH11). Primary
mouse T cells were activated using bead-bound anti-CD3 and anti-CD28 in
the presence of 50 U/ml recombinant mouse IL-2 andmaintained at a concen-
tration of 0.5–0.75 million cells/ml in RPMI growth medium supplemented with
10% FBS, 1 mM glutamine, and 0.001% 2-mercaptoethanol. Fas receptors
were activated by anti-mouse Fas (CD95) Jo2 clone in 0.5 mg/ml Protein G.
Alternatively, apoptosis was induced by culturing T cells with plate-bound
(10 mg/ml) anti-Fas antibody (see Supplemental Experimental Procedures).
Biochemical Analysis of TRPM7 Cleavage
LN18 cells were lysed in ice-cold lysis buffer (20 mM Tris-HCl, 150 mM NaCl,
1.0% Triton X-100 [pH 8.0]) containing protease and phosphatase inhibitor
cocktail (Pierce). Immunoprecipitations were carried out using the C47 anti-
body (2 mg/ml) or N74/25 antibody (50 ml hybridoma supernatant/ml) at 4C
for 12–16 hr. TRPM7 was detected by immunoblotting with C-47 antibody
(2 mg/ml). For in vitro cleavage, the 35S-labeled TRPM7 C-terminal polypeptide
sequences (aa 1,364–1,863) were synthesized in vitro using the TNT-T7 (Prom-
ega). A total of 2 ml of reaction mixture containing the 35S-labeled polypeptide
was incubated with 2 U of purified caspase-8 in 15 ml of AMC buffer (20 mM
PIPES [pH 7.2], 100 mM NaCl, 1 mM EDTA, 0.1% CHAPS, 10% sucrose,
10 mMDTT, 1 mg/ml Pefablock SC) at 37C for 2.5 hr prior to analysis by elec-
trophoresis and autoradiography. See Supplemental Experimental Proce-
dures for additional methods pertaining to biochemical analysis of TRPM7
cleavage.
DISC Analysis
SKW6.4 cells were stimulated with 2 mg/ml of anti-Fas antibody (clone APO-1-
1; Kamiya Biomedical) at 37C and lysed at indicated time points. The lysis
buffer (30 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% Triton X-100, and 10%
glycerol) was supplemented with protease inhibitor cocktail (Roche) immedi-
ately before use. For the untreated or 0 min condition, antibody was added
after lysis of unstimulated cells. The DISC (Fas immunoprecipitate) wasmulation with Alexa 568-conjugated anti-Fas antibody. The images shown are
wn in green for better contrast). Red arrowheadsmark the cells with internalized
t internalized).
cells at indicated time points, as detected microscopically.
n (1 hr) with Alexa 568-conjugated anti-Fas antibody. The images are of Alexa
red (appears orange in merged image) and DIC in green for contrast. Red
cells with Fas at the plasma membrane (not internalized).
1 hr of Fas stimulation as detected microscopically.
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Figure 7. Lung Inflammation and Airspace Enlargement in M7–/fl (lck-Cre) Mice
(A) H&E of lung sections from WT and M7-/fl (lck-Cre) (KO) mice.
(B) Statistical box charts of lung morphometric measurements comparing the alveolar airspaces in WT and KO lungs. Each data point in the box charts denotes
a measurement from a lung sample derived from a distinct mouse. The minimum number of airspace areas analyzed per lung sample was 47; total airspace area
analyzed was 693 (WT) and 446 (KO). Top panel presents calculated MLI, a metric of airspace enlargement (see Experimental Procedures). Bottom panel
illustrates deq of calculated airspace areas. The image-processing steps and calculations used to calculate these parameters are illustrated in Figure S3 and
detailed in Supplemental Experimental Procedures.
(C) Representative images of IHC-stained lung sections fromWT andM7-/fl (lck-Cre) (KO) mice. The T cells (left panels) were stained using the anti-CD3 antibody,
and the B cells (right panels) were stained using the anti-B220 antibody.
(D) Immunohistochemical detection of neutrophils (anti-Ly6 antibody).
(E) Box charts quantifying cells found in a microscopic field (403). Statistics pertaining to lung pathology are shown as Box (±SEM), vertical bars (±SD), and data
overlap.
See also Figure S7.
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Fas Signaling Regulates TRPM7 by Caspase Cleavageisolated by incubating the lysates with protein A Sepharose for 2 hr at 4C and
washed with lysis buffer prior to separation by SDS-PAGE and immunoblot-
ting. For caspase-8 assays, the lysis buffer was supplemented with 0.5 mM1160 Developmental Cell 22, 1149–1162, June 12, 2012 ª2012 ElsevMG-132 protease inhibitor. Caspase-8 was immunoprecipitated from lysates
and washed thoroughly in the lysis buffer prior to activity assays. The immuno-
precipitated pellets were resuspended in caspase-Glo 8 reagent (Promega).ier Inc.
Developmental Cell
Fas Signaling Regulates TRPM7 by Caspase CleavageThe cleavage reactions were incubated for 30 min at room temperature, and
relative luminescence was measured. siRNA cocktail was composed of
5 nM M7siR#2 and 5 nM M7siR#3 (see Supplemental Experimental
Procedures).Fas Internalization
Cells plated in glass-bottomed dishes were cultured in synthetic serum-free
medium (Opti-MEM; Invitrogen) for 6 hr prior to internalization assays. Cells
were incubated with 2 mg/ml Alexa 568-conjugated anti-Fas antibody (CH11
clone; Millipore) for 15 min in cell culture conditions (antibody-binding phase).
The cells were washed in Opti-MEM (37C) and images acquired using an
Olympus FV1000 confocal microscope (maintained at 37C during imaging).
siRNA cocktail was composed of 5 nM M7siR#2 and 5 nM M7siR#3 (see
Supplemental Experimental Procedures).Electrophysiology
In case of CHO cells, standard bath solution contained 135 mM Na-methane-
sulfonate (Na-MeSO3), 5 mM CsCl, 1 mM CaCl2, 10 mM HEPES (pH 7.4) with
NaOH. The standard pipette solution was 120 mM Cs-MeSO3, 5 mM CsCl,
10 mM BAPTA, 3.1 mM CaCl2, 3 mM ATP-Na, 0.6 mM GTP-Na, 10 mM
HEPES (pH 7.2) with CsOH. Signals were sampled at 10 Khz and low-pass
filtered at 2 kHz. For Jurkat cells and LN18 cells, the modified methods are
described in the Supplemental Experimental Procedures. In shRNA-treated
Jurkat cells, the TRPM7-dependent component of outward current (IMIC)
was defined by superfusion of 5 mM extracellular Mg2+ to block IMIC. Currents
were measured at +100mV following voltage ramps from 100mV; holding
potential was 0mV.Histology and Immunohistochemistry
Immediately after euthanizing 13- to 15-month-old mice, the lungs were in-
flated and fixed by intratracheal instillation of freshly prepared 5% buffered
PFA, excised, and immersed in the same fixative for 24 hr. The fixed tissue
samples were embedded in paraffin, sectioned into 4–6 mm slices, and H&E.
Immunohistochemistry (IHC) experiments were in formalin-fixed, paraffin-
embedded tissue sections (see Supplemental Experimental Procedures).
See Figure S7 and Supplemental Experimental Procedures for lung morpho-
metric measurements.Box Charts and Statistics
Statistics pertaining to the lung pathology are shown as Box (±SEM), vertical
bars (±SD), and data overlap. Statistics pertaining to TRPM7 currents are
shown as box (±SEM), vertical bars (5th95th percentile), and data overlap.
All individual data points are shown; the mean value is denoted by an empty
square, and the median is shown as a horizontal line. p values were calculated
using Student’s t test and ANOVA.SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, Supplemental Experimental
Procedures, and twomovies and can be found with this article online at doi:10.
1016/j.devcel.2012.04.006.ACKNOWLEDGMENTS
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